Bone News and Research

RSS

Plexxikon commences PLX3397 Phase 2 trial in patients with Hodgkin lymphoma

Plexxikon today announced that it has treated the first patient in a Phase 2 clinical trial in Hodgkin lymphoma with PLX3397. This novel agent is an oral, selective inhibitor that down-modulates two key cell types that are thought to mediate the progression of Hodgkin lymphoma tumors — macrophages and mast cells.

8 Mar 2011

Roundup: Medicaid cuts coming in Pa., Kansas; Mass. insurance hikes

Come Tuesday morning, bad news will abound in the Capitol - and it will be in the billions. That is when Gov. Corbett is to unveil, at last, the closely guarded details of his first state budget to the legislature and the people of Pennsylvania.

8 Mar 2011

New clinical trial to assess antiretroviral treatment in HIV-infected individuals based on CD4 counts

A major new clinical trial seeks to determine whether HIV-infected asymptomatic individuals have less risk of developing AIDS or other serious illness if they begin taking antiretrovirals sooner rather than later, based on their level of CD4+ T-cells.

8 Mar 2011

New study: Circadian system may contribute to daily pattern of vasovagal syncope

Fainting, or syncope, is quite common. About 50% of people will experience fainting at some point during their lifetime. The most common type of fainting is vasovagal syncope that is caused by a sudden drop in blood pressure resulting in reduced blood flow to the brain.

8 Mar 2011

New Lupus drug marching towards approval

A new drug for lupus from the Human Genome Sciences Inc is all set to get clearance in the US this week. If all goes through, this drug will offer patients the first approved treatment option in a half-century, setting the manufacturer up for huge sales.

7 Mar 2011

Hadasit, Yissum license innovative regenerative membrane implant to RegeneCure

Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, and Hadasit Medical Research Services & Development Ltd., the technology transfer company of the Hadassah University Medical Center, today announced that they have licensed innovative regenerative membrane implant technology to RegeneCure, which will further develop and commercialize the technology for bone tissue engineering for applications in trauma, spine, and reconstructive cranial and facial orthopedics.

7 Mar 2011

iPrEx update, bone mineral density study highlighted at day three of 18th CROI

The 18th Conference on Retroviruses and Opportunistic Infections is being held at the Hynes Convention Center in Boston from February 27 through March 2. Day three of this major HIV/AIDS research conference included the following selected presentations from scientists supported by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

5 Mar 2011

Shares of Bacterin's common stock receive approval for listing on NYSE Amex

Bacterin International Holdings, Inc., a creator and developer of revolutionary bone graft material and anti-infective coatings for medical applications, today announced that its common stock has been approved for listing on the NYSE Amex and has chosen Knight Capital Group as its designated market maker.

5 Mar 2011

Philips introduces new innovative and cost-effective solutions for radiology at ECR 2011

At the European Congress of Radiology 2011, Royal Philips Electronics is ushering in a new era in radiology science with Imaging 2.0, a concept fueled by integration of technology, clinician and patient.

5 Mar 2011

Denture wearers advised to pay special attention to consumption of zinc

From its involvement in a healthy immune system to its role in cell growth, zinc is an essential mineral for the human body. Zinc deficiency is a worldwide problem that affects approximately 4 million people in the U.S. alone.

5 Mar 2011

Nephros completes its shareholders rights offering, related private placement financing

Nephros, Inc., a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today announced the completion of its rights offering and private placement that together will result in gross proceeds of approximately $3.2 million to Nephros.

5 Mar 2011

Researchers use qMRI to confirm effect of CS treatment in patients with OA

A group of Canadian researchers led by Prof. Jean-Pierre Pelletier, Head of the Osteoarthritis Research Unit at the University of Montreal Hospital Research Centre, published a clinical trial in which they confirm, for the first time using quantitative Magnetic Resonance Imaging, the disease modifying effects of chondroitin sulphate, a symptomatic slow acting drug for osteoarthritis.

5 Mar 2011

Study: Overweight adolescents may have high risk of less bone mass

Overweight adolescents already struggling with risk factors such as insulin resistance may need to add weak bones to their list of health concerns, researchers report.

5 Mar 2011

Study: BMP can improve dental implant success

Using a bone-creating protein to augment the maxillary sinus could improve dental implant success, according to Georgia Health Sciences University researchers.

5 Mar 2011

ThermoGenesis prices offering of 2,250,000 shares of common stock

ThermoGenesis Corp., a leading supplier of innovative products and services that process and store adult stem cells, said today that it has determined the pricing for an offering of shares and warrants.

4 Mar 2011

Sangamo's preclinical ZFN-gene modification studies for HIV/AIDS treatment presented at CROI

Sangamo BioSciences, Inc. announced that data from its programs to develop ZFN-based therapeutic approaches for the treatment of HIV/AIDS were discussed in four oral presentations at the 18th Conference on Retroviruses and Opportunistic Infections, held in Boston from February 27 to March 2, 2011.

4 Mar 2011

Hazardous high concentrations of cadmium found in inexpensive children's jewelry

Young children who mouth or swallow jewelry containing cadmium may be exposed to as much as 100 times the recommended maximum exposure limit for the toxic metal, according to research published online March 4 ahead of print in the peer-reviewed journal Environmental Health Perspectives (EHP). The study measured bioavailability, or how much cadmium leached out of the jewelry. The research also found that damaged pieces of jewelry in some cases leached up to 30 times more cadmium than undamaged pieces.

4 Mar 2011

CT scanning offers benefit to patients undergoing dental implant surgery

Computerized tomography has proved a useful tool in reconstructive dental implant surgery where a bone graft is required. It provides reliable information in diagnosis and treatment planning and has been used to determine the volume of bone for grafts.

4 Mar 2011

AAOS releases clinical practice guideline to treat rotator cuff tears

The American Academy of Orthopaedic Surgeons Board of Directors approved and released a clinical practice guideline for treating rotator cuff tears.

4 Mar 2011

$Chemotherapy, endocrine therapy may increase risk of bone fractures in breast cancer survivors$

Chemotherapy, endocrine therapy may increase risk of bone fractures in breast cancer survivors

The combined effects of chemotherapy and endocrine therapy may increase the risk of bone fractures in breast cancer survivors.

4 Mar 2011

Bone News and Research

Plexxikon commences PLX3397 Phase 2 trial in patients with Hodgkin lymphoma

Roundup: Medicaid cuts coming in Pa., Kansas; Mass. insurance hikes

New clinical trial to assess antiretroviral treatment in HIV-infected individuals based on CD4 counts

New study: Circadian system may contribute to daily pattern of vasovagal syncope

New Lupus drug marching towards approval

Hadasit, Yissum license innovative regenerative membrane implant to RegeneCure

iPrEx update, bone mineral density study highlighted at day three of 18th CROI

Shares of Bacterin's common stock receive approval for listing on NYSE Amex

Philips introduces new innovative and cost-effective solutions for radiology at ECR 2011

Denture wearers advised to pay special attention to consumption of zinc

Nephros completes its shareholders rights offering, related private placement financing

Researchers use qMRI to confirm effect of CS treatment in patients with OA

Study: Overweight adolescents may have high risk of less bone mass

Study: BMP can improve dental implant success

ThermoGenesis prices offering of 2,250,000 shares of common stock

Sangamo's preclinical ZFN-gene modification studies for HIV/AIDS treatment presented at CROI

Hazardous high concentrations of cadmium found in inexpensive children's jewelry

CT scanning offers benefit to patients undergoing dental implant surgery

AAOS releases clinical practice guideline to treat rotator cuff tears

Chemotherapy, endocrine therapy may increase risk of bone fractures in breast cancer survivors

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News